In what could be considered a revolutionary breakthrough, scientists have created a “universal” vaccine formula that protects ...

Immunotherapy has transformed the treatment landscape for many cancers, yet its efficacy remains highly variable across tumor types and patient populations.

Interest in the use and impacts of glucagon-like peptide-1 receptor agonists in rheumatology has exploded over the past year, a trend that appeared to crescendo at ACR Convergence 2025. There, ...

Researchers developed a nasal vaccine that provides broad protection against respiratory viruses, bacteria, and allergens in ...